z-logo
Premium
Effect of Meals on the Kinetics of Etretinate
Author(s) -
Colburn W. A.,
Gibson D. M.,
Rodriguez L. C.,
Buggé C. J. L.,
Blumenthal H. P.
Publication year - 1985
Publication title -
the journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.92
H-Index - 116
eISSN - 1552-4604
pISSN - 0091-2700
DOI - 10.1002/j.1552-4604.1985.tb02881.x
Subject(s) - etretinate , crossover study , ingestion , meal , chemistry , washout , metabolite , dosing , pharmacokinetics , oral administration , plasma concentration , endocrinology , medicine , zoology , food science , biochemistry , placebo , biology , dermatology , alternative medicine , pathology , psoriasis
Eight healthy men received 100 mg oral doses of etretinate separated by two‐week washout periods in an open, randomized, crossover study. Etretinate was administered during a complete fast, with a standard high fat breakfast, a standard high carbohydrate breakfast, and 16 ounces of whole milk. Plasma samples were obtained at specific times over a 48‐hour period. Plasma concentrations of etretinate as well as two of its major metabolites were determined by a specific, reverse‐phase, high‐performance liquid chromatography method. Plasma concentrations of etretinate were greater when administered with a high fat meal and whole milk compared to ingestion with a high carbohydrate meal or during a complete fast. In contrast, there was no increase in the plasma concentrations of the active metabolites following any of the meals. These data indicate that chronic dosing of etretinate with milk or a high fat meal compared with fasting conditions will result in higher concentrations of etretinate, which may ultimately lead to higher metabolite concentrations.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom